| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President-tellenger Subsidiary | President | Chief Executive Officer +1 more
1 company
Stanley Arthur Reese last filed a Form 4 in July 2022, as President-tellenger Subsidiary at AIFF. Stanley Arthur Reese's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 142,565 shares of AIFF. The AIFF filings lean toward selling, a net 22,000 shares.
Stanley Arthur Reese has 10 Form 4 filings on record from April 2016 to July 2022, all as President-tellenger Subsidiary at Firefly Neuroscience (AIFF), 2016–2022.
The 13 reported transactions were 7 option or other derivative awards, 2 option exercises, 2 stock awards and 1 disposition back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $4K.
The only open-market sale was 22,000 shares of AIFF at an average $0.19 on December 13, 2018, about $4K.
Shares as reported in the last Form 4 for each company; the most recent is from July 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2018 | AIFF Firefly Neuroscience, Inc. | Chief Operating Officer | Sell | 22,000 | $0.19 | $4,180.00 | -100% |